Hypertriglyceridemic pancreatitis: Epidemiology, pathophysiology and clinical management

Published on Jan 22, 2018in United European gastroenterology journal3.549
· DOI :10.1177/2050640618755002
Nicolò de Pretis8
Estimated H-index: 8
(University of Verona),
Antonio Amodio13
Estimated H-index: 13
(University of Verona),
Luca Frulloni58
Estimated H-index: 58
(University of Verona)
Sources
Abstract
Hypertriglyceridemic pancreatitis (HTGP) typically occurs in patients with an underlying dyslipidemia (such as type I, IV or V dyslipidemia) and in the presence of a secondary condition, such as inadequately controlled diabetes, excess alcohol consumption or medication use. Although the symptoms of HTGP are similar to those of acute pancreatitis from other etiologies, HTGP is often associated with greater clinical severity and rate of complications. Therefore, accurate diagnosis of HTGP is essential so that patients receive the appropriate treatment. Novel therapies that aim to reduce the incidence of pancreatitis in this patient population are now available or in development. Understanding the etiology, pathophysiology and clinical characteristics of HTGP will enable future development of therapeutic agents to treat HTGP.
Download
📖 Papers frequently viewed together
160 Citations
187 Citations
201319.82Gut
2,517 Citations
References48
Newest
#1Johnson C DH-Index: 1
#2Besselink M GH-Index: 1
Last. 吴东H-Index: 1
view all 5 authors...
2,694 Citations
#1Georgios I. Papachristou (University of Pittsburgh)H-Index: 49
#2Jorge D. Machicado (University of Pittsburgh)H-Index: 13
Last. Amir Gougol (University of Pittsburgh)H-Index: 6
view all 33 authors...
Background We have established a multicenter international consortium to better understand the natural history of acute pancreatitis (AP) worldwide and to develop a platform for future randomized clinical trials. Methods The AP patient registry to examine novel therapies in clinical experience (APPRENTICE) was formed in July 2014. Detailed web-based questionnaires were then developed to prospectively capture information on demographics, etiology, pancreatitis history, comorbidities, risk factors...
22 CitationsSource
#1Dahn L. Clemens (UNMC: University of Nebraska Medical Center)H-Index: 23
#2Katrina J. Schneider (UNMC: University of Nebraska Medical Center)H-Index: 3
Last. Shailender Singh (UNMC: University of Nebraska Medical Center)H-Index: 11
view all 6 authors...
Acute pancreatitis is a necro-inflammatory disease of the exocrine pancreas that is characterized by inappropriate activation of zymogens, infiltration of the pancreas by inflammatory cells, and destruction of the pancreatic exocrine cells. Acute pancreatitis can progress to a severe life-threatening disease. Currently there is no pharmacotherapy to prevent or treat acute pancreatitis. One of the more common factors associated with acute pancreatitis is alcohol abuse. Although commonly associate...
23 CitationsSource
Abstract Severe hypertriglyceridemia is a common indication for the need of plasma exchange in treatment of hypertriglyceridemic-induced pancreatitis when normal therapies fail to garner a response. Application of plasmapheresis to prevent complication of hypertriglyceridemia is limited because of its cost and availability. We present a case of a 44-year-old man with metabolic syndrome and a medical history of secondary polycythemia in obesity hypoventilation syndrome, whose laboratory tests rev...
7 CitationsSource
#1Steven E. Gryn (UWO: University of Western Ontario)H-Index: 10
#2Robert A. HegeleH-Index: 112
We provide an overview of recent advances in the therapy of hypertriglyceridemia, focusing on several new therapies with potential for treating of familial chylomicronemia, other forms of hypertriglyceridemia, and for triglyceride-lowering in patients with other lipid disorders.Newer triglyceride-lowering modalities under evaluation include gene therapy for lipoprotein lipase deficiency (alipogene tiparvovec), and antisense oligonucleotides against mRNA for apolipoproteins B (mipomersen) and C3 ...
27 CitationsSource
Abstract Aim Acute Pancreatitis (AP) secondary to hypertriglyceridaemia (HTG) is a rare association of which little is known in the literature. This study investigates patient characteristics and outcomes (reoccurrence and mortality) in those presenting with AP secondary to HTG in one of the largest reported British cohorts. Methods A retrospective observational case note review of all patients treated at our institution between 2004 and 2012. Data are expressed as mean and standard deviation if...
24 CitationsSource
#1Qiuxiang Xu (Capital Medical University)H-Index: 2
#2Sumei Wang (Capital Medical University)H-Index: 3
Last. Zhenyu Zhang (Capital Medical University)H-Index: 13
view all 3 authors...
Abstract Objective To assess the incidence, causes, clinical characteristics, and outcomes of cases of acute pancreatitis in pregnancy (APIP). Methods A retrospective review was conducted of the medical records of pregnant women who were diagnosed with APIP at any point during pregnancy, labor, or the puerperium and attended Beijing Chaoyang Hospital, China, between January 1, 1991, and March 31, 2014. Results Among 34 292 pregnant women admitted to the center during the study period, 36 patient...
16 CitationsSource
#1Mary Abraham (Drexel University)H-Index: 2
#2Jennifer Mitchell (Drexel University)H-Index: 1
Last. James Gasperino (Drexel University)H-Index: 7
view all 4 authors...
Norethindrone acetate/ethinyl estradiol (Estrostep; Warner Chilcott, Rockaway, New Jersey) is an “estrophasic” type of oral contraceptive, which combines a continuous low progestin dose with a gradually increasing estrogen dose. In clinical trials, this medication failed to produce clinically significant changes in serum lipid levels. We report a case of severe hypertriglyceridemia-induced acute pancreatitis in a 24-year-old woman caused by Estrostep, occurring nearly 10 years after she began us...
11 CitationsSource
#1Raju Panta (SHM: Society of Hospital Medicine)H-Index: 3
#2Khagendra Dahal (SHM: Society of Hospital Medicine)H-Index: 14
Last. Sumit Kunwar (SHM: Society of Hospital Medicine)H-Index: 1
view all 3 authors...
Background Low-density lipoprotein cholesterol (LDL-C) is the primary target of lipid-lowering therapy in people at risk for cardiovascular diseases. Mipomersen inhibits apolipoprotein B-100 (apoB) synthesis and causes reduction in LDL-C by reducing apoB. Objective We aimed to perform a meta-analysis of all published randomized controlled trials comparing safety and efficacy of mipomersen with placebo in adults with dyslipidemia. Methods We searched PUBMED, CENTRAL, and EMBASE from inception thr...
45 CitationsSource
#1Charles D. Meyers (Novartis)H-Index: 10
#2Karine Tremblay (UdeM: Université de Montréal)H-Index: 24
Last. Daniel Gaudet (UdeM: Université de Montréal)H-Index: 74
view all 6 authors...
Background Familial chylomicronemia syndrome (FCS) is a rare lipid disease caused by complete lipoprotein lipase (LPL) deficiency resulting in fasting chylomicronemia and severe hypertriglyceridemia. Inhibition of diacylglycerol acyltransferase 1 (DGAT1), which mediates chylomicron triglyceride (TG) synthesis, is an attractive strategy to reduce TG levels in FCS. In this study we assessed the safety, tolerability and TG-lowering efficacy of the DGAT1 inhibitor pradigastat in patients with FCS.
57 CitationsSource
Cited By37
Newest
#1Chukwuka Akamnonu (RU: Rutgers University)
#2Masako Ueda (UPenn: University of Pennsylvania)
Last. Ankit Shah (RU: Rutgers University)H-Index: 4
view all 0 authors...
Abstract null Background null /Objective: Familial partial lipodystrophy type 2 (FPLD2) is a rare genetic condition characterized by partial lack of subcutaneous tissue and can predispose an individual to complications including hypertriglyceridemia with pancreatitis, insulin resistance and diabetes. This report describes a case of FPLD2 identified with judicious history and Examination. null Case Report null This case describes a 32 year old patient with recurrent pancreatitis who developed com...
Source
Source
#2Amna AltkritH-Index: 1
Last. Jay NfonoyimH-Index: 7
view all 5 authors...
Source
#1Emily Freier (Drake University)
#2Lynn E. Kassel (Drake University)H-Index: 3
Last. Bhavana Chinnakotla (MU: University of Missouri)H-Index: 2
view all 4 authors...
Source
Triglycerides (TG) are the most important molecules for the energy reserve of our body. After their hepatic or intestinal synthesis from fatty acids, they are carried by chylomicrons (QM (intestinal origin) or VLDL (hepatic origin) in plasma. Their catabolism is determined by the action of the lipoprotein lipase protein complex (LPL) and the hepatic receptors (RLDL and LRP-1) are responsible for their clearance are. Changes in the production or catabolism leads to hypertriglyceridaemia (HTG). Th...
Source
Acute pancreatitis (AP) is an acute destructive inflammatory condition of the pancreas. Hypertriglyceridaemia is the third most common worldwide cause of AP. Although the presentation of hypertriglyceridaemic pancreatitis (HTGP) is usually similar to other forms of AP, it may cause more severe AP and worse symptoms. Therefore, apart from the supportive care and treatment for AP, it is necessary to treat the underlying aetiology. There are no established guidelines for managing HTGP. Many treatme...
Source
#1Yinan Guo (Capital Medical University)H-Index: 1
#2Weikai Hu (Capital Medical University)
Last. Chenghong Yin (Capital Medical University)H-Index: 6
view all 8 authors...
Acute pancreatitis is one of the leading causes of gastrointestinal disorder-related hospitalizations, yet its pathogenesis remains to be fully elucidated. Postsynaptic density protein-95 (PSD-95) ...
Source
#1Panupong Upala (MFU: Mae Fah Luang University)H-Index: 5
#2Tawatchai Apidechkul (MFU: Mae Fah Luang University)H-Index: 10
Last. Ratipark Tamornpark (MFU: Mae Fah Luang University)H-Index: 5
view all 9 authors...
BACKGROUND Triglycerides are lipids in the human body that are produced from the consumption of daily food and drink. However, elevated serum triglycerides, also known as hypertriglyceridemia (HTG), are key biomarkers indicating an unhealthy status and increased risks of cardiovascular diseases (CVDs) and pancreatitis. Different groups of people have different patterns and styles of cooking and different patterns of consumption, such as hill tribe people, who have their own unique culture and co...
Source
Source
There is an increasing prevalence of type 2 diabetes mellitus (DM) among adolescents due to obesity. Diabetes can cause hypertriglyceridemia, defined as triglyceride (TG) levels above 150 mg/dl, leading to severe complications, including cardiovascular events, fatty liver disease, and acute pancreatitis. We present a case of acute pancreatitis manifested by both hypertriglyceridemia and new-onset DM. The risk of hypertriglyceridemia-induced pancreatitis (HTGP) significantly increases at triglyce...
Source